Standout Papers

Ranibizumab for Neovascular Age-Related Macular Degeneration 2006 2026 2012 2019 4.5k
  1. Ranibizumab for Neovascular Age-Related Macular Degeneration (2006)
    Philip J. Rosenfeld, David M. Brown et al. New England Journal of Medicine
  2. Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration (2006)
    David M. Brown, Peter K. Kaiser et al. New England Journal of Medicine

Immediate Impact

9 by Nobel laureates 18 from Science/Nature 122 standout
Sub-graph 1 of 19

Citing Papers

Age-Related Macular Degeneration
2024 Standout
Tumour vasculature at single-cell resolution
2024 StandoutNature
21 intermediate papers

Works of Robert Y. Kim being referenced

Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
2006 Standout

Author Peers

Author Last Decade Papers Cites
Robert Y. Kim 650 639 362 6873 5312 77 8.7k
David R. Guyer 42 439 334 6378 4296 74 8.8k
Jason S. Slakter 36 287 353 8070 5278 131 9.0k
John A. Sorenson 39 292 319 8284 5223 92 9.0k
John D. Earle 9 1267 2086 2016 1115 126 6.8k
John L. Hungerford 12 412 419 2715 802 121 3.6k
Andrew Schachat 12 151 246 5266 3053 138 6.3k
Karin Dieckmann 29 436 3006 527 1162 214 6.3k
Malin Sund 151 505 410 207 339 132 3.8k
Véronique Mosseri 57 1397 1145 276 353 122 7.2k
T.A. DeWees 250 799 1607 100 1095 174 3.8k

All Works

Loading papers...

Rankless by CCL
2026